PPARA and Hepatic fibrosis: It has been hypothesized that the weak effect of PPARα agonists in human could be related to the lower expression of PPARα in human liver compared to mouse or to an inverse correlation between progressive stages of liver fibrosis and hepatic PPARα [54,59].